LENSAR (NASDAQ:LNSR) Upgraded at Wall Street Zen

Key Points

• Wall Street Zen upgraded LENSAR from “sell” to “hold,” while analysts’ overall consensus remains “Hold” with an $11.00 price target. BTIG raised its target to $9.00 and assigned a “Buy” rating, while Lake Street maintained a $13.00 target and “Buy” rating.
• LENSAR reported a quarterly earnings beat, with $16.5 million in revenue and $0.10 earnings per share versus expectations for $14.65 million in revenue and a $0.16 loss. The company also placed 10 ALLY systems, bringing its installed base to 445, with a 13-system backlog.
• Institutional investors increased their holdings, and institutions now own approximately 40.15% of LENSAR. Shares opened at $8.20, compared with a 52-week range of $4.95 to $12.96.

LENSAR (NASDAQ:LNSR - Get Free Report) was upgraded by Wall Street Zen from a "sell" rating to a "hold" rating in a research report issued to clients and investors on Saturday.

Several other equities research analysts also recently issued reports on LNSR. BTIG Research lifted their price objective on LENSAR from $7.00 to $9.00 and gave the stock a "buy" rating in a report on Thursday. Lake Street Capital reiterated a "buy" rating and set a $13.00 target price on shares of LENSAR in a research note on Thursday. Finally, Weiss Ratings reissued a "sell (d+)" rating on shares of LENSAR in a research report on Friday, August 7th. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, LENSAR has an average rating of "Hold" and a consensus price target of $11.00.

LENSAR Price Performance

Shares of LENSAR stock opened at $8.20 on Friday. LENSAR has a 1-year low of $4.95 and a 1-year high of $12.96. The company has a market capitalization of $100.70 million, a PE ratio of -24.85 and a beta of 0.89. The business has a 50-day moving average of $5.89 and a 200-day moving average of $7.37.

LENSAR (NASDAQ:LNSR - Get Free Report) last released its quarterly earnings results on Thursday, August 13th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of ($0.16) by $0.26. The business had revenue of $16.50 million for the quarter, compared to analysts' expectations of $14.65 million. LENSAR had a negative return on equity of 253.03% and a net margin of 57.57%.

Institutional Investors Weigh In On LENSAR

A number of institutional investors have recently modified their holdings of the stock. Credit Industriel ET Commercial grew its stake in LENSAR by 0.8% in the fourth quarter. Credit Industriel ET Commercial now owns 124,483 shares of the company's stock worth $1,448,000 after purchasing an additional 1,000 shares in the last quarter. BNP Paribas Financial Markets increased its holdings in LENSAR by 129.0% in the third quarter. BNP Paribas Financial Markets now owns 2,008 shares of the company's stock valued at $25,000 after buying an additional 1,131 shares during the last quarter. JPMorgan Chase & Co. raised its stake in LENSAR by 26.8% during the third quarter. JPMorgan Chase & Co. now owns 5,928 shares of the company's stock valued at $73,000 after buying an additional 1,254 shares in the last quarter. Barclays PLC raised its stake in LENSAR by 10.3% during the fourth quarter. Barclays PLC now owns 14,857 shares of the company's stock valued at $173,000 after buying an additional 1,389 shares in the last quarter. Finally, Vanguard Group Inc. lifted its holdings in LENSAR by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 507,603 shares of the company's stock worth $6,269,000 after buying an additional 1,446 shares during the last quarter. Institutional investors and hedge funds own 40.15% of the company's stock.

Key Stories Impacting LENSAR

Here are the key news stories impacting LENSAR this week:

• Positive Sentiment: LENSAR reported second-quarter revenue of $16.5 million, above analysts’ $14.65 million consensus estimate, and earnings of $0.10 per share versus expectations for a $0.16 loss. The results point to a significant improvement in profitability and operating performance. LENSAR Reports Second Quarter 2026 Results and Provides Business Update
• Positive Sentiment: The company placed 10 ALLY Robotic Cataract Laser Systems during the quarter, increasing its installed base to 445 systems. The ALLY backlog stood at 13 systems at June 30, suggesting continued near-term demand and potential future revenue. LENSAR signals opex to rise modestly as ALLY backlog reaches 13 systems
• Positive Sentiment: Recurring revenue reached $13.7 million, while ALLY placements grew 30%. The recurring-revenue base could improve visibility and support more consistent results as the installed system base expands. LENSAR Q2 2026 Earnings Call Highlights
• Positive Sentiment: BTIG Research raised its LENSAR price target from $7 to $9 and assigned a Buy rating, reflecting greater confidence following the earnings beat and business update.
• Neutral Sentiment: Management indicated that operating expenses will increase modestly, likely reflecting investments needed to support commercialization and the growing ALLY system base. This could temper the pace of future margin expansion.

About LENSAR

LENSAR, Inc, headquartered in Orlando, Florida, is a medical technology company specializing in advanced laser systems for ophthalmic surgery. Its flagship product, the LENSAR Laser System, combines proprietary three-dimensional imaging with precision-guided femtosecond laser delivery to perform critical steps in cataract procedures, including capsulotomy creation, lens fragmentation and corneal incisions.

Founded in 2005, LENSAR has concentrated its research and development efforts on enhancing surgical accuracy and patient outcomes in cataract treatment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source